The U.S. Court of Appeals for the Federal Circuit on April 26 upheld a recent lower court ruling that found an active pharmaceutical ingredient imported by Janssen Ortho eligible for duty-free treatment. In line with a February 2020 Court of International Trade decision, the Federal Circuit found darunavir ethanolate, the active ingredient in a Janssen HIV medication, is encompassed by a listing in the tariff schedule's Pharmaceutical Appendix for darunavir.
Court of Federal Appeals Trade activity
to
articlessource documents
Refine Trend Search
Clear Terms
Search Primer
Term list: Separate terms with spaces, not commas or semicolons.
Multi-word term: Place inside quotes to ensure an exact match (e.g. "surrogate value").
Acronyms: Use all capital letters to ensure the search is not looking for that letter sequence instead. (e.g., CIT).
Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +ruling).
Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., ruling -NY).
Simplest form: Use the simplest form of a term (e.g. "russian export control" instead of "russian export controls") or "entity list" instead of "entity listing" or "entity listed").